Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Pivonello

Showing results (91-100 of 135) with videos related to

Pageof 14
Sort By:
Journal of Endocrinological Investigation|January 24, 1998
Short stature and azoospermia in a patient with Y chromosome long arm deletionM De Rosa, D De Brasi, S Zarrilli, et al.
American Journal of Physiology. Endocrinology and Metabolism|September 23, 2000
Age-related decrease of somatostatin receptor number in the normal human thymusD Ferone, R Pivonello, P M Van Hagen, et al.
Journal of Endocrinological Investigation|November 28, 2019
Towards the tailoring of glucocorticoid replacement in adrenal insufficiency: the Italian Society of Endocrinology Expert OpinionA M Isidori, G Arnaldi, M Boscaro, et al.
The Journal of Clinical Endocrinology and Metabolism|June 14, 2000
Macroprolactinoma shrinkage during cabergoline treatment is greater in naive patients than in patients pretreated with other dopamine agonists: a prospective study in 110 patientsA Colao, A Di Sarno, M L Landi, et al.
The Journal of Clinical Endocrinology and Metabolism|November 10, 2001
Resistance to cabergoline as compared with bromocriptine in hyperprolactinemia: prevalence, clinical definition, and therapeutic strategyA Di Sarno, M L Landi, P Cappabianca, et al.
Journal of Endocrinological Investigation|September 11, 2023
Pasireotide effects on biochemical control and glycometabolic profile in acromegaly patients switched from combination therapies or unconventional dosages of somatostatin analogsG Corica, R Pirchio, A Milioto, et al.
Eye (London, England)|April 9, 2015
Evaluation of the retinal nerve fibre layer and ganglion cell complex thickness in pituitary macroadenomas without optic chiasmal compressionG Cennamo, R S Auriemma, D Cardone, et al.
The Journal of Clinical Endocrinology and Metabolism|September 16, 1999
A longitudinal study of vasopressin cell antibodies, posterior pituitary function, and magnetic resonance imaging evaluations in subclinical autoimmune central diabetes insipidusA De Bellis, A Colao, F Di Salle, et al.
Clinical Endocrinology|January 29, 2008
Effect of long-term cabergoline therapy on the immunological pattern and pituitary function of patients with idiopathic hyperprolactinaemia positive for antipituitary antibodiesA De Bellis, A Colao, A Savoia, et al.
Journal of Endocrinological Investigation|May 3, 2011
Glycometabolic control in acromegalic patients with diabetes: a study of the effects of different treatments for growth hormone excess and for hyperglycemiaV M Cambuli, M Galdiero, M Mastinu, et al.
Pageof 14

Showing results (91-100 of 135) with videos related to

Sort By:
Pageof 14
Journal of Endocrinological Investigation|January 24, 1998
Short stature and azoospermia in a patient with Y chromosome long arm deletionM De Rosa, D De Brasi, S Zarrilli, et al.
American Journal of Physiology. Endocrinology and Metabolism|September 23, 2000
Age-related decrease of somatostatin receptor number in the normal human thymusD Ferone, R Pivonello, P M Van Hagen, et al.
Journal of Endocrinological Investigation|November 28, 2019
Towards the tailoring of glucocorticoid replacement in adrenal insufficiency: the Italian Society of Endocrinology Expert OpinionA M Isidori, G Arnaldi, M Boscaro, et al.
The Journal of Clinical Endocrinology and Metabolism|June 14, 2000
Macroprolactinoma shrinkage during cabergoline treatment is greater in naive patients than in patients pretreated with other dopamine agonists: a prospective study in 110 patientsA Colao, A Di Sarno, M L Landi, et al.
The Journal of Clinical Endocrinology and Metabolism|November 10, 2001
Resistance to cabergoline as compared with bromocriptine in hyperprolactinemia: prevalence, clinical definition, and therapeutic strategyA Di Sarno, M L Landi, P Cappabianca, et al.
Journal of Endocrinological Investigation|September 11, 2023
Pasireotide effects on biochemical control and glycometabolic profile in acromegaly patients switched from combination therapies or unconventional dosages of somatostatin analogsG Corica, R Pirchio, A Milioto, et al.
Eye (London, England)|April 9, 2015
Evaluation of the retinal nerve fibre layer and ganglion cell complex thickness in pituitary macroadenomas without optic chiasmal compressionG Cennamo, R S Auriemma, D Cardone, et al.
The Journal of Clinical Endocrinology and Metabolism|September 16, 1999
A longitudinal study of vasopressin cell antibodies, posterior pituitary function, and magnetic resonance imaging evaluations in subclinical autoimmune central diabetes insipidusA De Bellis, A Colao, F Di Salle, et al.
Clinical Endocrinology|January 29, 2008
Effect of long-term cabergoline therapy on the immunological pattern and pituitary function of patients with idiopathic hyperprolactinaemia positive for antipituitary antibodiesA De Bellis, A Colao, A Savoia, et al.
Journal of Endocrinological Investigation|May 3, 2011
Glycometabolic control in acromegalic patients with diabetes: a study of the effects of different treatments for growth hormone excess and for hyperglycemiaV M Cambuli, M Galdiero, M Mastinu, et al.
Pageof 14